Patient-derived xenografts undergo mouse-specific tumor evolution.
about
Divergent evolutionary trajectories in transplanted tumor models.Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.Advances in Precision Medicine: Tailoring Individualized Therapies.The latest animal models of ovarian cancer for novel drug discovery.Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy.Current Challenges and Opportunities in Treating Glioblastoma.Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.The use of whole exome sequencing and murine patient derived xenografts as a method of chemosensitivity testing in sarcoma.Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.Use of patient-derived xenograft mouse models in cancer research and treatment.Engineering Breast Cancer Microenvironments and 3D Bioprinting.Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics.Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field.Organoids Provide an Important Window on Inflammation in Cancer.XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence dataGenetics and biology of prostate cancerOrthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapyA patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaThe contributions of cancer cell metabolism to metastasisModeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem CellsOrganoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeuticsCase study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment responseNext-Generation Modeling of Human CancersThe Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer CareMolecular Diagnostics in Clinical OncologyIntegrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinomaOrganoid technology and applications in cancer researchBlocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survivalPatient-Derived Xenograft Models for Endometrial Cancer ResearchMouse models in the era of large human tumour sequencing studiesProtocol for the avatar acceptability study: a multiperspective cross-sectional study evaluating the acceptability of using patient-derived xenografts to guide personalised cancer care in Australia and New ZealandThe chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research
P2860
Q46273744-AC63CBAD-870B-4403-9DC2-8A4B3B3FD1D4Q47114983-D9BA1686-C2FC-4AB5-96F2-59EFB58F1363Q47160721-F8113E7C-7DF6-4055-96CB-42423334982BQ47553013-CC2280E4-32A9-4B38-B909-62B13D39D4BBQ47773621-2A86FC5D-2D5F-41F6-AF8D-BB04C5C9F443Q49843607-CF1ECD7A-76A1-4FBF-A7DB-4F2A23AC1D42Q50327117-0FC15F37-2267-4860-9077-F4F74B9B6524Q52579808-ABAB7F8F-BEC2-416A-A667-BEEAF3290637Q52625303-64753616-D824-4471-942C-8203EDD5BC1EQ52655025-02EB89D9-C392-4312-89E7-3AFEB0CEC459Q52657766-58019ED4-9F70-4004-8E58-F341B8BAA4D8Q54983279-DC0DAD1C-39F6-479C-AC7F-6E3DD96EA1B2Q55001892-946DE176-455F-4D43-9B47-BF80790F3405Q55088548-0F236199-BF77-45AC-A851-6C1C21FECEC5Q55113686-E89C3B0D-156C-4DB5-BE80-AE5BFEF00262Q55148658-04D6C3AC-2DDA-47E6-A900-D20E4C125DA0Q55302559-FEEDBD11-80C6-42E2-9CD7-955FFFE69F6EQ57024703-6BDD003B-FD16-4432-9611-6615CA21D7FCQ57106917-F2324541-988F-4693-B874-2B03857EF217Q57174120-77C4C2AD-FFC2-46C7-9FCF-CF46E5AF39F2Q57174849-63FED249-28B6-472B-B1C2-DB9F3145483FQ57188839-C9ECFF64-6836-4D9B-B9B8-F54FB2ACAA94Q57490090-CCC58EB7-45B7-44D1-BE52-376A84FA425AQ57900923-2FF1B96D-BFD8-4D18-847F-06909AC13F7AQ58198401-657507D0-6D70-4380-9FC4-597B8CA02222Q58576103-640837AA-CBA8-446E-BB14-6472E4631DC0Q58697933-D353AF5C-4680-4339-B8A0-2AC3C637AA42Q58700723-8548B610-3F89-4FAF-A391-F28EE89FCD6AQ58711257-5BCE64E4-8976-4572-95E6-CCE2D97F0496Q58737628-6A25BF25-C9B0-4D3D-87DB-7315EC80398CQ58743974-04C22B24-5D5C-4994-8D35-6490C826E5D1Q58768056-6D0934A0-F59D-4F86-8DF5-0768143BAD4BQ58776633-30B6CA3B-79B6-4F66-8AFF-2CB87EEA47BDQ58795555-13402F5F-D090-4F9F-B8E9-E4DAF69AE14AQ58804592-82EFAEC2-4E8B-4B66-BF6E-255E19B742B9
P2860
Patient-derived xenografts undergo mouse-specific tumor evolution.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Patient-derived xenografts undergo mouse-specific tumor evolution.
@en
Patient-derived xenografts undergo mouse-specific tumor evolution.
@nl
type
label
Patient-derived xenografts undergo mouse-specific tumor evolution.
@en
Patient-derived xenografts undergo mouse-specific tumor evolution.
@nl
prefLabel
Patient-derived xenografts undergo mouse-specific tumor evolution.
@en
Patient-derived xenografts undergo mouse-specific tumor evolution.
@nl
P2093
P2860
P50
P356
P1433
P1476
Patient-derived xenografts undergo mouse-specific tumor evolution
@en
P2093
James M McFarland
Rameen Beroukhim
Uri Ben-David
Yuen-Yi Tseng
P2860
P2888
P304
P356
10.1038/NG.3967
P407
P577
2017-10-09T00:00:00Z